These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15711113

  • 1. CA9 expression as a prognostic factor in renal clear cell carcinoma.
    Soyupak B, Erdoğan S, Ergin M, Seydaoğlu G, Kuzgunbay B, Tansuğ Z.
    Urol Int; 2005; 74(1):68-73. PubMed ID: 15711113
    [Abstract] [Full Text] [Related]

  • 2. [Clinicopathological study and immunohistochemical expression of CA9 in cystic multilocular renal cell carcinomas].
    Li G, Badin G, Berremila S, Obadia F, Tostain J, Péoc'h M.
    Prog Urol; 2012 Sep; 22(10):572-6. PubMed ID: 22920335
    [Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
    Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS.
    J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
    [Abstract] [Full Text] [Related]

  • 5. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
    Choi SW, Kim JY, Park JY, Cha IH, Kim J, Lee S.
    Hum Pathol; 2008 Sep; 39(9):1317-22. PubMed ID: 18440050
    [Abstract] [Full Text] [Related]

  • 6. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
    Li G, Passebosc-Faure K, Lambert C, Gentil-Perret A, Blanc F, Oosterwijk E, Mosnier JF, Genin C, Tostain J.
    Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
    [Abstract] [Full Text] [Related]

  • 7. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis.
    de Martino M, Klatte T, Seligson DB, LaRochelle J, Shuch B, Caliliw R, Li Z, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    J Urol; 2009 Aug; 182(2):728-34. PubMed ID: 19539328
    [Abstract] [Full Text] [Related]

  • 8. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ.
    Cancer Res; 1997 Jul 15; 57(14):2827-31. PubMed ID: 9230182
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J, Li G, Gentil-Perret A, Gigante M.
    Eur J Cancer; 2010 Dec 15; 46(18):3141-8. PubMed ID: 20709527
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Kamei S, Deguchi T, Hirose Y.
    Oncol Rep; 2008 Sep 15; 20(3):525-30. PubMed ID: 18695901
    [Abstract] [Full Text] [Related]

  • 11. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
    Hoogsteen IJ, Marres HA, Wijffels KI, Rijken PF, Peters JP, van den Hoogen FJ, Oosterwijk E, van der Kogel AJ, Kaanders JH.
    Clin Cancer Res; 2005 Jan 01; 11(1):97-106. PubMed ID: 15671533
    [Abstract] [Full Text] [Related]

  • 12. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
    Kang HJ, Kim IH, Sung CO, Shim JH, Yu E.
    Virchows Arch; 2015 Apr 01; 466(4):403-13. PubMed ID: 25577552
    [Abstract] [Full Text] [Related]

  • 13. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma.
    Prayson RA, Chamberlain WA, Angelov L.
    Appl Immunohistochem Mol Morphol; 2010 Oct 01; 18(5):422-8. PubMed ID: 20453815
    [Abstract] [Full Text] [Related]

  • 14. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G, Bilal I, Gentil-Perret A, Feng G, Zhao A, Peoc'h M, Genin C, Tostain J, Gigante M.
    Urol Oncol; 2012 Oct 01; 30(4):463-8. PubMed ID: 20822935
    [Abstract] [Full Text] [Related]

  • 15. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
    Gu M.
    Int J Clin Exp Pathol; 2015 Oct 01; 8(1):862-6. PubMed ID: 25755787
    [Abstract] [Full Text] [Related]

  • 16. Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapy.
    Kim HS, Kim WS, Park SH, Jung CW, Choi HY, Lee HM, Jeon SS, Ha H, Hwang IG, Lee S, Lim HY.
    Urol Oncol; 2010 Oct 01; 28(2):157-63. PubMed ID: 18976937
    [Abstract] [Full Text] [Related]

  • 17. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL.
    Cancer Res; 2001 Nov 01; 61(21):7992-8. PubMed ID: 11691824
    [Abstract] [Full Text] [Related]

  • 18. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L, Biesová Z, Pastoreková S, Kettmann R, Pastorek J.
    Int J Oncol; 2005 Apr 01; 26(4):1121-7. PubMed ID: 15754010
    [Abstract] [Full Text] [Related]

  • 19. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX, Ireland J, Rayman P, Finke J, Zhou M.
    Urology; 2010 Feb 01; 75(2):257-61. PubMed ID: 19963243
    [Abstract] [Full Text] [Related]

  • 20. CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy.
    Li G, Feng G, Gentil-Perret A, Genin C, Tostain J.
    Clin Exp Metastasis; 2007 Feb 01; 24(3):149-55. PubMed ID: 17390110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.